Allscripts Healthcare Solutions (NASDAQ:MDRX) was upgraded by analysts at Thomson Reuters/Verus from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, American Banking News.com reports.
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 2.83% on Monday, hitting $14.595. 830,924 shares of the company’s stock traded hands. Allscripts Healthcare Solutions has a 1-year low of $8.85 and a 1-year high of $16.43. The stock has a 50-day moving average of $14.55 and a 200-day moving average of $14.48. The company’s market cap is $2.601 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.03. The company had revenue of $334.00 million for the quarter, compared to the consensus estimate of $355.30 million. During the same quarter in the previous year, the company posted $0.23 earnings per share. The company’s revenue for the quarter was down 7.5% on a year-over-year basis. On average, analysts predict that Allscripts Healthcare Solutions will post $0.28 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Leerink Swann upgraded shares of Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating in a research note to investors on Friday. They now have a $18.00 price target on the stock, up previously from $16.00. Separately, analysts at Robert W. Baird raised their price target on shares of Allscripts Healthcare Solutions from $17.00 to $18.00 in a research note to investors on Friday, November 8th. Finally, analysts at Cowen and Company raised their price target on shares of Allscripts Healthcare Solutions from $18.00 to $20.00 in a research note to investors on Friday, November 8th. Twelve investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $16.68.
Allscripts Healthcare Solutions, Inc (NASDAQ:MDRX) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.